Viatris (VTRS) stock news

Viatris (VTRS) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-30 12:40:00 UTC#545606newconfirmedpress release

Viatris commences tender offer to acquire all outstanding shares of Pacira BioSciences

pr newswireimportance 0.80trust 1.00Viatris Inc. +0.40Pacira BioSciences, Inc. +0.60Peach Purchaser Sub Inc. +0.20

2026-10-21 15:30:00 UTC#494129newconfirmednews

JPMorgan maintains Neutral rating on Viatris Inc.

dow_jonesimportance 0.30trust 0.70Viatris Inc. 0JPMorgan Chase & Co. 0

2026-10-16 16:55:40 UTC#473195duplicateconfirmednews

Viatris and Opus Genetics receive FDA label expansion for Ryzumvi to treat presbyopia

seeking alphaimportance 0.30trust 0.70Viatris Inc. +0.40Opus Genetics +0.40Ryzumvi +0.40+1 entities

2026-10-16 16:00:00 UTC#472930duplicateconfirmednews

Opus Genetics receives FDA approval for RYZUMVI label expansion to treat presbyopia in adults

tradingviewimportance 0.60trust 0.70Opus Genetics, Inc. +0.70Viatris Inc. +0.50RYZUMVI +0.70+1 entities

2026-10-13 14:00:15 UTC#452873newconfirmednews

Seeking Alpha reports analyst rating changes for META, VTRS, MRVL, and COKE

seeking alphaimportance 0.30trust 0.70Meta Platforms, Inc. +0.20Viatris Inc. 0Marvell Technology, Inc. 0+1 entities

2026-10-09 14:45:46 UTC#439031newconfirmednews

RBC Capital maintains Sector Perform rating on Pacira BioSciences with $36.50 price target

tradingviewimportance 0.40trust 0.70Pacira BioSciences, Inc. 0RBC Capital Markets, LLC 0Viatris Inc. 0+2 entities

2026-10-08 20:01:45 UTC#434805duplicateconfirmednews

Daily M&A Roundup: Devon Energy Sells Eagle Ford Assets to Crescent for $4.2B; Viatris-Pacira Deal Confirmed

reutersimportance 0.40trust 0.80Starbucks Corporation +0.20Chipotle Mexican Grill, Inc. +0.20Devon Energy Corporation +0.30+2 entities

2026-10-08 16:01:00 UTC#433693duplicateconfirmednews

Viatris to acquire Pacira BioSciences for $1.65 billion in cash at $36.50 per share

dow_jonesimportance 0.30trust 0.90Pacira BioSciences, Inc. +0.80Viatris Inc. +0.20Exparel +0.50+2 entities

2026-10-08 13:45:29 UTC#432826duplicateconfirmednews

Daily M&A Roundup: Viatris to Acquire Pacira for $1.65B, iFood Eyes Caju, and Insurance Brokerage Acquisitions

reutersimportance 0.40trust 0.90Prosus N.V. +0.10iFood +0.20Caju +0.20+2 entities

2026-10-08 12:25:00 UTC#432213duplicateconfirmednews

Viatris to acquire Pacira BioSciences for $1.65 billion in cash at $36.50 per share

dow_jonesimportance 0.40trust 0.90Viatris Inc. +0.10Pacira BioSciences, Inc. +0.60Exparel +0.30+2 entities

2026-10-08 12:10:05 UTC#432053duplicateconfirmednews

Viatris to acquire Pacira BioSciences for $36.50 per share in $1.65 billion cash deal

reutersimportance 0.40trust 0.90Viatris Inc. +0.40Pacira BioSciences, Inc. +0.60

2026-10-08 11:58:00 UTC#432015duplicateconfirmednews

Viatris to acquire Pacira BioSciences for $1.65 billion in cash at $36.50 per share

dow_jonesimportance 0.40trust 0.90Viatris Inc. +0.20Pacira BioSciences, Inc. +0.60

2026-10-08 11:56:47 UTC#431994duplicateconfirmednews

Viatris to acquire Pacira BioSciences for $36.50 per share in cash

seeking alphaimportance 0.40trust 0.70Viatris Inc. +0.30Pacira BioSciences, Inc. +0.60

2026-10-08 11:56:25 UTC#431968duplicateconfirmednews

Viatris to acquire Pacira BioSciences for $1.65 billion in cash deal

reutersimportance 0.30trust 0.90Viatris Inc. +0.30Pacira BioSciences, Inc. +0.50

2026-10-08 11:50:39 UTC#431984duplicateconfirmednews

Viatris to acquire Pacira BioSciences in $1.65 billion deal

reutersimportance 0.40trust 0.90Viatris Inc. +0.30Pacira BioSciences, Inc. +0.50

2026-10-08 11:49:36 UTC#431937duplicateconfirmednews

Viatris to acquire Pacira BioSciences for $1.65 billion

reutersimportance 0.40trust 0.90Viatris Inc. +0.30Pacira BioSciences, Inc. +0.40

2026-10-08 11:45:00 UTC#431932duplicateconfirmedpress release

Viatris to Acquire Pacira BioSciences to Expand Non-Opioid Pain Therapy Portfolio with EXPAREL and ZILRETTA

pr newswireimportance 0.60trust 1.00Viatris Inc. +0.40Pacira BioSciences, Inc. +0.50EXPAREL +0.50+1 entities

2026-10-08 11:45:00 UTC#431907newconfirmednews

Viatris to Acquire Pacira BioSciences to Expand Non-Opioid Pain Therapy Portfolio

dow_jonesimportance 0.70trust 0.90Viatris Inc. +0.40Pacira BioSciences, Inc. +0.60

2026-10-05 20:53:00 UTC#415981newconfirmednews

UBS maintains Buy rating on Viatris

dow_jonesimportance 0.30trust 0.60Viatris Inc. +0.20UBS Group AG +0.20

2026-10-05 10:59:00 UTC#412935newconfirmedpress release

Viatris Inc. to report third-quarter 2026 financial results on November 5, 2026

pr_newswireimportance 0.30trust 1.00Viatris Inc. 0